Related references
Note: Only part of the references are listed.The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study
Katie Spencer et al.
LANCET ONCOLOGY (2021)
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer et al.
LANCET ONCOLOGY (2021)
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study
Simon P. Bach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Initiation of the Global Coalition for Radiotherapy during the COVID-19 pandemic
Pat Price et al.
LANCET ONCOLOGY (2020)
International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic
C. A. M. Marijnen et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer Center
Paul B. Romesser et al.
ADVANCES IN RADIATION ONCOLOGY (2020)
Making an IMPACT: A priority setting consultation exercise to improve outcomes in patients with locally advanced, recurrent and metastatic colorectal cancer
A. E. Vallance et al.
EJSO (2019)
Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer
R. Clifford et al.
BRITISH JOURNAL OF SURGERY (2018)